Advertisement

Lercanidipine, Enalapril, and Their Combination in the Treatment of Elderly Hypertensive Patients

  • Juan Garcia Puig
  • Carlos Calvo
  • Olavi Luurila
  • Harri Luurila
  • Sakari Sulosaari
  • Arto Strandberg
  • Cristina Ghezzi
Conference paper

Abstract

Several trials have shown that hypertensive patients whose blood pressure (BP) is brought under control (< 140/90 mmHg) have significantly fewer cardiovascular events than patients whose BP remains uncontrolled [1]. However, despite the availability of multiple antihypertensive drugs, BP is difficult to control, especially systolic BP and in elderly patients [2]. In most clinical trials aimed at controlling BP, more than two antihypertensive drugs are almost always required. The importance of combination therapy has been emphasized in current guidelines [3]. Adding a second antihypertensive drug may be a better option in non-controlled patients than switching to a different drug or increasing the dose of the first compound.

Keywords

Ambulatory Blood Pressure Monitoring Office Blood Pressure Elderly Hypertensive Patient Dihydropyridine Calcium Antagonist Office Systolic Blood Pressure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Benetos A, Thomas F, Bean KE, Guize L (2003) Why cardiovascular mortality is higher in treated hypertensives versus subjects of the same age, in the general population. J Hypertens 21:1635–1640PubMedCrossRefGoogle Scholar
  2. 2.
    Mancia G, Grassi G (2002) Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens 20:1461–1464PubMedCrossRefGoogle Scholar
  3. 3.
    Chobanian AV, Bakris GL, Black HR et al (2003) The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. JAMA 289:2560–2572PubMedCrossRefGoogle Scholar
  4. 4.
    Borghi C (2005) Lercanidipine in hypertension. Vasc Health Risk Manag 1:173–182PubMedGoogle Scholar
  5. 5.
    Todd PA, Goa LG (1992) Enalapril: a reappraisal of its pharmacology and therapeutic use in hypertension. Drugs 43:346–381PubMedCrossRefGoogle Scholar
  6. 6.
    Julius S, Kjeldsen E, Weber M et al (2004) Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 363:2022–2031PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • Juan Garcia Puig
    • 1
  • Carlos Calvo
    • 2
  • Olavi Luurila
    • 3
  • Harri Luurila
    • 3
  • Sakari Sulosaari
    • 4
  • Arto Strandberg
    • 4
  • Cristina Ghezzi
    • 5
  1. 1.La Paz University HospitalMadrid
  2. 2.Santiago de CompostelaHospital Clinico UniversitarioSpain
  3. 3.Kaisaniemen Lääkariasema OyHelsinki
  4. 4.Keravan LääkärikeskusKeravaFinland
  5. 5.Medical DepartmentRecordati S.p.A.MilanItaly

Personalised recommendations